Skip to main content
Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
3.160
-0.150 (-4.53%)
At close: Mar 6, 2026

Cellectis Revenue

Cellectis had revenue of $37.16M USD in the quarter ending September 30, 2025, with 105.89% growth. This brings the company's revenue in the last twelve months to $82.55M, up 129.04% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.

Revenue (ttm)
$82.55M
Revenue Growth
+129.04%
P/S Ratio
3.25
Revenue / Employee
$371.85K
Employees
222
Market Cap
228.55M EUR

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 202059.56M36.57M159.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Transgene 7.58M
Genfit 45.13M
MaaT Pharma 3.92M
Innate Pharma 12.64M
Sensorion 5.65M
Adocia 12.88M
ABIONYX Pharma 4.33M
OSE Immunotherapeutics 1.78M
Revenue Rankings

Cellectis News

More News